It is a pharma private limited company based in Delhi, Delhi, India, established in 2014.
2014 | Delhi, Delhi, India | ActiveGetwell Therapeutics Private Limited, a active private limited company, was established on 09 July 2014 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24100DL2014PTC268703. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Manas Tandon (Director), Mini Tandon (Director). Past directors included Rajiv Tandon. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No 721, Sector 19 Pocket 3, Delhi, Delhi, 110075.
U24100DL2014PTC268703
268703
09 July 2014
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Getwell Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manas Tandon | Director | 09 Jul 2014 | Current |
| Mini Tandon | Director | 09 Jul 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Jan 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Getwell Therapeutics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 58.81% increase in profit. The company's net worth observed a substantial decline by a decrease of 23.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Getwell Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Getwell Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Getwell Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Getwell Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Getwell Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Getwell Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Manas Tandon was appointed as a Director was appointed as a Director on 09 Jul 2014 & has been associated with this company since 11 years 4 months . was completed.
Progress on Mini Tandon was appointed as a Director was appointed as a Director on 09 Jul 2014 & has been associated with this company since 11 years 4 months . was documented.
Progress on Getwell Therapeutics Private Limited was registered on 09 Jul 2014 with Roc Delhi & aged 11 years 4 months as per MCA records. was documented.
The CIN of Getwell Therapeutics Private Limited is U24100DL2014PTC268703.
Getwell Therapeutics Private Limited is headquartered at Flat No 721, Sector 19 Pocket 3, Delhi, Delhi, 110075.
Getwell Therapeutics Private Limited was incorporated on 09 July 2014.
The current directors of Getwell Therapeutics Private Limited are
The primary industry of Getwell Therapeutics Private Limited is Pharma.
Getwell Therapeutics Private Limited is unlisted.
The authorized capital of Getwell Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Getwell Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX